132 related articles for article (PubMed ID: 20633117)
1. Quinone reductase 2 and antidepressant effect of melatonin derivatives.
Oxenkrug GF; Bachurin SO; Prakhie IV; Zefirov NS
Ann N Y Acad Sci; 2010 Jun; 1199():121-4. PubMed ID: 20633117
[TBL] [Abstract][Full Text] [Related]
2. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate.
Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G
J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489
[TBL] [Abstract][Full Text] [Related]
3. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3.
Mailliet F; Ferry G; Vella F; Thiam K; Delagrange P; Boutin JA
FEBS Lett; 2004 Dec; 578(1-2):116-20. PubMed ID: 15581627
[TBL] [Abstract][Full Text] [Related]
4. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
Hirano S; Miyata S; Onodera K; Kamei J
Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA
Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234
[TBL] [Abstract][Full Text] [Related]
6. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.
Tan DX; Manchester LC; Terron MP; Flores LJ; Tamura H; Reiter RJ
J Pineal Res; 2007 Nov; 43(4):317-20. PubMed ID: 17910598
[TBL] [Abstract][Full Text] [Related]
7. X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.
Pegan SD; Sturdy M; Ferry G; Delagrange P; Boutin JA; Mesecar AD
Protein Sci; 2011 Jul; 20(7):1182-95. PubMed ID: 21538647
[TBL] [Abstract][Full Text] [Related]
8. Old and new inhibitors of quinone reductase 2.
Ferry G; Hecht S; Berger S; Moulharat N; Coge F; Guillaumet G; Leclerc V; Yous S; Delagrange P; Boutin JA
Chem Biol Interact; 2010 Jul; 186(2):103-9. PubMed ID: 20399199
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 .
Nosjean O; Nicolas JP; Klupsch F; Delagrange P; Canet E; Boutin JA
Biochem Pharmacol; 2001 Jun; 61(11):1369-79. PubMed ID: 11331072
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
Freitas AE; Budni J; Lobato KR; Binfaré RW; Machado DG; Jacinto J; Veronezi PO; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):335-43. PubMed ID: 20026371
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
[TBL] [Abstract][Full Text] [Related]
12. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
[TBL] [Abstract][Full Text] [Related]
14. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis.
Boutin JA; Saunier C; Guenin SP; Berger S; Moulharat N; Gohier A; Delagrange P; Cogé F; Ferry G
Arch Biochem Biophys; 2008 Sep; 477(1):12-9. PubMed ID: 18502195
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex.
Andreasen JT; Redrobe JP
Behav Pharmacol; 2009 May; 20(3):286-95. PubMed ID: 19404193
[TBL] [Abstract][Full Text] [Related]
16. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems.
Machado DG; Bettio LE; Cunha MP; Santos AR; Pizzolatti MG; Brighente IM; Rodrigues AL
Eur J Pharmacol; 2008 Jun; 587(1-3):163-8. PubMed ID: 18457827
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system.
Machado DG; Bettio LE; Cunha MP; Capra JC; Dalmarco JB; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):642-50. PubMed ID: 19286446
[TBL] [Abstract][Full Text] [Related]
19. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
Hughes ZA; Liu F; Platt BJ; Dwyer JM; Pulicicchio CM; Zhang G; Schechter LE; Rosenzweig-Lipson S; Day M
Neuropharmacology; 2008 Jun; 54(7):1136-42. PubMed ID: 18423777
[TBL] [Abstract][Full Text] [Related]
20. A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.
Du H; Wang J; Zhang X; Hu Z
Eur J Med Chem; 2008 Dec; 43(12):2861-9. PubMed ID: 18400335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
